Scientists Restore Nerve Function to Combat Chronic Pain
How Damaged Nerves Lose Power—and How They’re Revived
Researchers at Duke University have developed a method to reverse chronic nerve pain by restoring electrical function in damaged nerves. The breakthrough, announced May 24, 2026, offers hope for millions who experience severe pain from everyday sensations.
Current pain treatments often mask symptoms without addressing root causes. This new approach targets the underlying issue: disrupted electrical signaling in injured nerves. When nerves are damaged, their ability to transmit signals deteriorates, leading to hypersensitivity. The Duke team found that boosting energy production within nerve cells helps repair this signaling, effectively „recharging” them.
Nerves rely on mitochondria—the cell’s power plants—to generate the energy needed for signal transmission. After injury, mitochondrial function drops, weakening nerve responses. The researchers used a compound that enhances mitochondrial efficiency, restoring electrical activity in animal models. In tests, previously pain-sensitive subjects responded normally to touch within days. „We’re not blocking pain signals—we’re fixing the broken system generating them,” said lead scientist Dr. Elena Torres.
Could This Replace Opioids for Nerve Pain?
The treatment was delivered via localized injection, minimizing systemic side effects. Early data show sustained relief after a single dose, with no signs of tolerance or dependency—common drawbacks of opioids. The therapy targets peripheral nerves, which connect the spinal cord to the rest of the body, making it suitable for conditions like diabetic neuropathy and post-surgical nerve damage.
With opioid alternatives urgently needed, this method represents a potential paradigm shift. Over 20 million Americans suffer from peripheral neuropathy, many relying on drugs that dull pain but impair daily function. „Patients describe putting on socks as torture,” Torres explained. „If we can restore normal nerve behavior, we restore quality of life.”
The therapy is not yet approved for humans, but clinical trials are expected to begin by late 2027. Researchers caution that results in animals don’t always translate, but the mechanism is conserved across species, raising optimism. If successful, it could reduce reliance on addictive painkillers and offer long-term relief.
Frequently Asked Questions
How does this treatment differ from current painkillers? Most painkillers block pain signals in the brain or nerves. This therapy repairs the nerve’s ability to transmit signals normally, addressing the cause rather than the symptom.
When might this be available to patients? Human trials are expected by late 2027. If all goes well, approval could come by 2030, pending safety and effectiveness results.
Could it work for all types of chronic pain? It targets nerve damage-related pain, such as diabetic neuropathy or injury-induced conditions. It won’t apply to inflammatory or central nervous system disorders like fibromyalgia.